Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and ...

Please see full Prescribing Information, including Patient Information: <a ...

Participants were assigned to one of three groups: lorundrostat 50 mg once daily; lorundrostat 50 mg once daily with the ...

A hormone disorder called primary aldosteronism may be driving as many as 1 in 5 cases of high blood pressure, according to ...

I’m sitting in my GP’s office, explaining for the sixth time that I know my hair loss, memory problems and missed periods aren’t normal. “I think you’re a bit stressed,” she tells me.

A new drug called baxdrostat may offer another treatment option for people who have both chronic kidney disease and difficult ...

Since the mornings and evenings have suddenly become cooler, my numbers have been slightly higher than usual.Even though I am ...

Heart failure is serious, but a Penn State Health cardiologist says many patients can feel better and stay active with ...

Some common blood pressure medicines may offer extra protection for people with brain aneurysms, according to research ...

The mechanism of controlling the human body with 'chemical signals'What I found interesting while researching hormones is ...

RADNOR, PA — Mineralys Therapeutics, Inc. (NASDAQ: MLYS) will present new long-term efficacy and safety data for lorundrostat ...

Five years ago, the approval of dapagliflozin for chronic kidney disease (CKD) by the US FDA marked a pivotal shift in ...